Thread Embedding Acupuncture vs Sham on Acute Pain and Quality of Life After Laparoscopic Nephrectomy of Living Donor
Comparison of Thread Embedding Acupuncture at the First Lumbar EX-B2 Point With Sham Thread Embedding Acupuncture on Acute Pain and Quality of Life After Laparoscopic Living Donor Nephrectomy
1 other identifier
interventional
32
1 country
1
Brief Summary
This randomized, double-blind controlled study aims to evaluate the effectiveness of thread implantation acupuncture at EX-B2 L1 in reducing postoperative pain and improving quality of life in patients undergoing laparoscopic living donor nephrectomy. Thirty-four participants will be randomly assigned to receive either thread implantation acupuncture with polydioxanone (PDO) thread at EX-B2 L1 plus standard postoperative therapy or sham thread implantation acupuncture without thread insertion plus the same standard therapy. Pain intensity will be assessed using the Visual Analogue Scale (VAS) and quality of life with the Short-Form 36 (SF-36). The study seeks to determine whether thread implantation acupuncture provides additional analgesic and quality-of-life benefits beyond standard postoperative care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable postoperative-pain
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2025
CompletedFirst Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2025
CompletedJanuary 8, 2026
January 1, 2026
9 months
November 17, 2025
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity (Visual Analogue Scale)
Visual Analogue Scale (0-100 mm) measured at Day 0 (baseline), Day 1, 2, 3, and 14 post-surgery.
From baseline to postoperative Day 14
Secondary Outcomes (3)
Change in Quality of Life (Short Form-36)
Baseline and Day 14.
Analgesic Use
Day 0-14.
Adverse Events Adverse Events Adverse Events
Up to Day 14
Study Arms (2)
Intervention Group
EXPERIMENTALThread implantation acupuncture
Control Group
SHAM COMPARATORSham thread implantation acupuncture
Interventions
Thread implantation acupuncture performed bilaterally at EX-B2 (L1) using polydioxanone (PDO) thread (26G × 38 mm) inserted subcutaneously to a depth of approximately 1-1.5 cm. The procedure is conducted once under aseptic conditions before surgery, combined with standard postoperative analgesic therapy.
Sham thread embedding acupuncture performed bilaterally at EX-B2 (L1) using a blunt needle without thread insertion, mimicking the procedure but without embedding material. Participants also receive standard postoperative therapy.
Eligibility Criteria
You may qualify if:
- Living kidney donors scheduled to undergo laparoscopic living donor nephrectomy.
- Aged 21-60 years.
- Willing to participate and able to sign written informed consent
You may not qualify if:
- Hypersensitivity to thread-embedding acupuncture (TEA).
- History of keloid formation or tendency to develop keloids.
- Skin disorders at or near the planned TEA insertion sites.
- Neurological abnormalities or lower-limb deficits on physical examination.
- History of spinal surgery or scheduled for spinal surgery within the next 7 months.
- Scoliosis based on clinical examination.
- Other causes of low back pain, such as inflammatory spondylitis, spinal infection, or tumor.
- Planning to become pregnant within 7 months after LNDH.
- Body Mass Index (BMI) \< 18 kg/m².
- Uncontrolled diabetes mellitus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitas Indonesia
Jakarta Pusat, Dki Jakarta, 10430, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
KEPK FKUI-RSCM
The Health Research Ethics Commitee - Faculty of Medicine Universitas Indonesia and Dr. Cipto Mangunkusumo National Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Blinding will be applied to participants and outcome assessors. Group allocation will not be disclosed to them to minimize assessment bias.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 21, 2025
Study Start
February 10, 2025
Primary Completion
November 10, 2025
Study Completion
December 10, 2025
Last Updated
January 8, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share